astilbin has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diao, H; Han, F; Jiang, W; Kang, Z | 1 |
| Fu, FH; Jiang, WL; Li, GS; Qu, GW; Tian, JW; Wu, J; Yue, XD | 1 |
2 other study(ies) available for astilbin and Alloxan Diabetes
| Article | Year |
|---|---|
Astilbin protects diabetic rat heart against ischemia-reperfusion injury via blockade of HMGB1-dependent NF-κB signaling pathway.
Topics: Animals; Blotting, Western; Diabetes Mellitus, Experimental; Flavonols; Heart; HMGB1 Protein; Inflammation Mediators; Male; Myocardial Reperfusion Injury; NF-kappa B; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction | 2014 |
Effect of astilbin on experimental diabetic nephropathy in vivo and in vitro.
Topics: Animals; Antioxidants; Body Weight; Cell Line; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Flavonols; Glucose; Humans; Kidney; Longevity; Male; Models, Animal; Phytotherapy; Plant Extracts; Random Allocation; Rats; Rats, Sprague-Dawley; Rhizome; Smilax; Transforming Growth Factor beta1 | 2009 |